Core Viewpoint - A class action lawsuit has been filed against Charming Medical Limited (NASDAQ: MCTA) due to allegations of securities fraud during a specific class period from October 10, 2025, to November 12, 2025, with a deadline for lead plaintiff motion set for February 17, 2026 [1][4]. Group 1: Lawsuit Details - The lawsuit alleges that Charming Medical Limited made materially false and misleading statements and failed to disclose adverse facts about its business and operations [4]. - Specific allegations include involvement in a fraudulent stock promotion scheme using social media misinformation and impersonation of financial professionals [4]. - It is claimed that insiders used offshore accounts to facilitate the dumping of shares during a price inflation campaign, and that the company's public statements omitted mention of false rumors and artificial trading activity [4]. Group 2: SEC Involvement - On November 11, 2025, the SEC halted trading of Charming securities due to potential manipulation linked to social media recommendations aimed at inflating the stock price and trading volume [3].
Law Offices of Howard G. Smith Encourages Charming Medical Limited (MCTA) Shareholders To Inquire About Securities Fraud Class Action